Formulation and evaluation of anti-rheumatic dexibuprofen transdermal patches: a quality-by-design approach

Authors:

Abstract
Dexibuprofen (DXIBN) transdermal patches were formulated using various concentrations of selected polymeric excipients (matrix material; ethyl cellulose and polyvinylpyrrolidone, plasticizer (di-N-butyl phthalate) and a conventional permeation enhancer (almond oil)). Initial patch formulations were evaluated for their physiochemical properties (thickness, moisture uptake, final moisture content and DXIBN content). Also, impact of patch components on resulting tensile strength and in vitro permeation were used to predict an optimal patch formulation using a quality by design (QbD) approach, which was subsequently evaluated and further compared to a commercial oral tablet dosage form for in vitro and in vivo release (rabbit model). Initially formulated patches demonstrated uniform thickness (0.44±0.02 cm), relatively low moisture uptake (7.87±1.11 w/w %) and highly acceptable drug loading values (100.0±0.026%). The tensile strength of patches increased significantly with matrix polymer concentration...

This publication has 16 references indexed in Scilit: